These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
199 related items for PubMed ID: 27988378
1. Cancer therapeutics with epigallocatechin-3-gallate encapsulated in biopolymeric nanoparticles. Tyagi N, De R, Begun J, Popat A. Int J Pharm; 2017 Feb 25; 518(1-2):220-227. PubMed ID: 27988378 [Abstract] [Full Text] [Related]
2. Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate. Siddiqui IA, Adhami VM, Bharali DJ, Hafeez BB, Asim M, Khwaja SI, Ahmad N, Cui H, Mousa SA, Mukhtar H. Cancer Res; 2009 Mar 01; 69(5):1712-6. PubMed ID: 19223530 [Abstract] [Full Text] [Related]
3. Epigallocatechin gallate-loaded polysaccharide nanoparticles for prostate cancer chemoprevention. Rocha S, Generalov R, Pereira Mdo C, Peres I, Juzenas P, Coelho MA. Nanomedicine (Lond); 2011 Jan 01; 6(1):79-87. PubMed ID: 21182420 [Abstract] [Full Text] [Related]
4. Epigallocatechin Gallate Nanodelivery Systems for Cancer Therapy. Granja A, Pinheiro M, Reis S. Nutrients; 2016 May 20; 8(5):. PubMed ID: 27213442 [Abstract] [Full Text] [Related]
5. Stability of (-)-epigallocatechin gallate and its activity in liquid formulations and delivery systems. Krupkova O, Ferguson SJ, Wuertz-Kozak K. J Nutr Biochem; 2016 Nov 20; 37():1-12. PubMed ID: 27770867 [Abstract] [Full Text] [Related]
6. Nanochemoprevention with therapeutic benefits: An updated review focused on epigallocatechin gallate delivery. Yang QQ, Wei XL, Fang YP, Gan RY, Wang M, Ge YY, Zhang D, Cheng LZ, Corke H. Crit Rev Food Sci Nutr; 2020 Nov 20; 60(8):1243-1264. PubMed ID: 30799648 [Abstract] [Full Text] [Related]
7. Nanochemoprevention: sustained release of bioactive food components for cancer prevention. Siddiqui IA, Adhami VM, Ahmad N, Mukhtar H. Nutr Cancer; 2010 Nov 20; 62(7):883-90. PubMed ID: 20924964 [Abstract] [Full Text] [Related]
8. Encapsulation of biophenolic phytochemical EGCG within lipid nanoparticles enhances its stability and cytotoxicity against cancer. Radhakrishnan R, Kulhari H, Pooja D, Gudem S, Bhargava S, Shukla R, Sistla R. Chem Phys Lipids; 2016 Jun 20; 198():51-60. PubMed ID: 27234272 [Abstract] [Full Text] [Related]
9. Potential Therapeutic Targets of Epigallocatechin Gallate (EGCG), the Most Abundant Catechin in Green Tea, and Its Role in the Therapy of Various Types of Cancer. Almatroodi SA, Almatroudi A, Khan AA, Alhumaydhi FA, Alsahli MA, Rahmani AH. Molecules; 2020 Jul 09; 25(14):. PubMed ID: 32660101 [Abstract] [Full Text] [Related]
10. Oral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model. Khan N, Bharali DJ, Adhami VM, Siddiqui IA, Cui H, Shabana SM, Mousa SA, Mukhtar H. Carcinogenesis; 2014 Feb 09; 35(2):415-23. PubMed ID: 24072771 [Abstract] [Full Text] [Related]
11. Targeted nanoparticles encapsulating (-)-epigallocatechin-3-gallate for prostate cancer prevention and therapy. Sanna V, Singh CK, Jashari R, Adhami VM, Chamcheu JC, Rady I, Sechi M, Mukhtar H, Siddiqui IA. Sci Rep; 2017 Feb 01; 7():41573. PubMed ID: 28145499 [Abstract] [Full Text] [Related]
12. Targeted biocompatible nanoparticles for the delivery of (-)-epigallocatechin 3-gallate to prostate cancer cells. Sanna V, Pintus G, Roggio AM, Punzoni S, Posadino AM, Arca A, Marceddu S, Bandiera P, Uzzau S, Sechi M. J Med Chem; 2011 Mar 10; 54(5):1321-32. PubMed ID: 21306166 [Abstract] [Full Text] [Related]
13. Epigallocatechin-3-gallate at the nanoscale: a new strategy for cancer treatment. Sun W, Yang Y, Wang C, Liu M, Wang J, Qiao S, Jiang P, Sun C, Jiang S. Pharm Biol; 2024 Dec 10; 62(1):676-690. PubMed ID: 39345207 [Abstract] [Full Text] [Related]
14. Anticancer activities of (-)-epigallocatechin-3-gallate encapsulated nanoliposomes in MCF7 breast cancer cells. de Pace RC, Liu X, Sun M, Nie S, Zhang J, Cai Q, Gao W, Pan X, Fan Z, Wang S. J Liposome Res; 2013 Sep 10; 23(3):187-96. PubMed ID: 23600473 [Abstract] [Full Text] [Related]
15. Perspectives on the recent developments with green tea polyphenols in drug discovery. Li F, Wang Y, Li D, Chen Y, Qiao X, Fardous R, Lewandowski A, Liu J, Chan TH, Dou QP. Expert Opin Drug Discov; 2018 Jul 10; 13(7):643-660. PubMed ID: 29688074 [Abstract] [Full Text] [Related]
16. Tumor-Homing Cell-Penetrating Peptide Linked to Colloidal Mesoporous Silica Encapsulated (-)-Epigallocatechin-3-gallate as Drug Delivery System for Breast Cancer Therapy in Vivo. Ding J, Yao J, Xue J, Li R, Bao B, Jiang L, Zhu JJ, He Z. ACS Appl Mater Interfaces; 2015 Aug 19; 7(32):18145-55. PubMed ID: 26225796 [Abstract] [Full Text] [Related]
17. From tea to treatment; epigallocatechin gallate and its potential involvement in minimizing the metabolic changes in cancer. Tauber AL, Schweiker SS, Levonis SM. Nutr Res; 2020 Feb 19; 74():23-36. PubMed ID: 31918176 [Abstract] [Full Text] [Related]
18. Therapeutic effects of EGCG: a patent review. Chakrawarti L, Agrawal R, Dang S, Gupta S, Gabrani R. Expert Opin Ther Pat; 2016 Aug 19; 26(8):907-16. PubMed ID: 27338088 [Abstract] [Full Text] [Related]
19. Nanochemoprevention by bioactive food components: a perspective. Siddiqui IA, Mukhtar H. Pharm Res; 2010 Jun 19; 27(6):1054-60. PubMed ID: 20221894 [Abstract] [Full Text] [Related]
20. Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets. Talib WH, Awajan D, Alqudah A, Alsawwaf R, Althunibat R, Abu AlRoos M, Al Safadi A, Abu Asab S, Hadi RW, Al Kury LT. Molecules; 2024 Mar 20; 29(6):. PubMed ID: 38543009 [Abstract] [Full Text] [Related] Page: [Next] [New Search]